Assembly Biosciences Inc
ASMB
NASDAQ
Biotechnology
$32.95
USD
+3.00 (+10.02%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $582.03M
Volume 557.6K
Revenue
$71.10M
TTM
+121.1%
YoY
Gross Margin
100%
TTM
0.0%
YoY
Net Income
$-6.38M
TTM
+84.0%
YoY
Operating Cash Flow
$-39.75M
TTM
+29.3%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 9.4 | 9.6 | 10.8 | 42.5 | 8.2 |
YoY Growth | +62.8% | +12.8% | +57.6% | +477.3% | -12.8% |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 9.4 | 9.6 | 10.8 | 42.5 | 8.2 |
Selling, General & Administrative | 4.5 | 4.6 | 5.1 | 5.4 | 4.7 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 19.4 | 20.7 | 21.7 | 22.7 | 19.6 |
Operating Income | -9.9 | -11.1 | -10.9 | 19.8 | -11.4 |
EBITDA | -9.9 | -11.1 | -10.9 | 19.8 | -11.3 |
Other Income / Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Other Income / Expense | 1.1 | 0.9 | 1.7 | 2.3 | 2.3 |
Income Before Income Taxes | -8.8 | -10.2 | -9.2 | 22.1 | -9.1 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -8.8 | -10.2 | -9.2 | 22.1 | -9.1 |
Consolidated Net Income / Loss | -8.8 | -10.2 | -9.2 | 22.1 | -9.1 |
Net Income Attributable to Common Shareholders | -8.8 | -10.2 | -9.2 | 22.1 | -9.1 |
Basic EPS | -$1.17 | -$1.33 | -$0.72 | $1.30 | -$0.54 |
Diluted EPS | -$1.17 | -$1.33 | -$0.72 | $1.30 | -$0.54 |
Basic Shares Outstanding | 7.5M | 7.7M | 12.7M | 17.0M | 16.9M |
Diluted Shares Outstanding | 7.5M | 7.7M | 12.7M | 17.0M | 16.9M |